207 related articles for article (PubMed ID: 29516642)
1. INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway.
Chen Y; Sun Z; Qi M; Wang X; Zhang W; Chen C; Liu J; Zhao W
J Cell Mol Med; 2018 May; 22(5):2935-2943. PubMed ID: 29516642
[TBL] [Abstract][Full Text] [Related]
2. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
[TBL] [Abstract][Full Text] [Related]
3. INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas.
Chi MN; Guo ST; Wilmott JS; Guo XY; Yan XG; Wang CY; Liu XY; Jin L; Tseng HY; Liu T; Croft A; Hondermarck H; Scolyer RA; Jiang CC; Zhang XD
Oncotarget; 2015 Nov; 6(37):39891-907. PubMed ID: 26573229
[TBL] [Abstract][Full Text] [Related]
4. SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer.
Gasser JA; Inuzuka H; Lau AW; Wei W; Beroukhim R; Toker A
Mol Cell; 2014 Nov; 56(4):595-607. PubMed ID: 25458846
[TBL] [Abstract][Full Text] [Related]
5. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers.
Fedele CG; Ooms LM; Ho M; Vieusseux J; O'Toole SA; Millar EK; Lopez-Knowles E; Sriratana A; Gurung R; Baglietto L; Giles GG; Bailey CG; Rasko JE; Shields BJ; Price JT; Majerus PW; Sutherland RL; Tiganis T; McLean CA; Mitchell CA
Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22231-6. PubMed ID: 21127264
[TBL] [Abstract][Full Text] [Related]
6. The INPP4B paradox: Like PTEN, but different.
Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
[TBL] [Abstract][Full Text] [Related]
7. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway.
Li D; Yang J; Ma H; Sun C; Feng R
J Cell Biochem; 2018 Dec; 119(12):9899-9909. PubMed ID: 30132953
[TBL] [Abstract][Full Text] [Related]
8. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
[TBL] [Abstract][Full Text] [Related]
9. In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.
Li Chew C; Lunardi A; Gulluni F; Ruan DT; Chen M; Salmena L; Nishino M; Papa A; Ng C; Fung J; Clohessy JG; Sasaki J; Sasaki T; Bronson RT; Hirsch E; Pandolfi PP
Cancer Discov; 2015 Jul; 5(7):740-51. PubMed ID: 25883022
[TBL] [Abstract][Full Text] [Related]
10. INPP4B overexpression suppresses migration, invasion and angiogenesis of human prostate cancer cells.
Chen H; Li H; Chen Q
Clin Exp Pharmacol Physiol; 2017 Jun; 44(6):700-708. PubMed ID: 28261855
[TBL] [Abstract][Full Text] [Related]
11. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase.
Bago R; Malik N; Munson MJ; Prescott AR; Davies P; Sommer E; Shpiro N; Ward R; Cross D; Ganley IG; Alessi DR
Biochem J; 2014 Nov; 463(3):413-27. PubMed ID: 25177796
[TBL] [Abstract][Full Text] [Related]
12. A tumor suppressor function for the lipid phosphatase INPP4B in melanocytic neoplasms.
Perez-Lorenzo R; Gill KZ; Shen CH; Zhao FX; Zheng B; Schulze HJ; Silvers DN; Brunner G; Horst BA
J Invest Dermatol; 2014 May; 134(5):1359-1368. PubMed ID: 24288008
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma.
Yuen JW; Chung GT; Lun SW; Cheung CC; To KF; Lo KW
PLoS One; 2014; 9(8):e105163. PubMed ID: 25126743
[TBL] [Abstract][Full Text] [Related]
14. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
Reed DE; Shokat KM
Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
[TBL] [Abstract][Full Text] [Related]
15. INPP4B is an oncogenic regulator in human colon cancer.
Guo ST; Chi MN; Yang RH; Guo XY; Zan LK; Wang CY; Xi YF; Jin L; Croft A; Tseng HY; Yan XG; Farrelly M; Wang FH; Lai F; Wang JF; Li YP; Ackland S; Scott R; Agoulnik IU; Hondermarck H; Thorne RF; Liu T; Zhang XD; Jiang CC
Oncogene; 2016 Jun; 35(23):3049-61. PubMed ID: 26411369
[TBL] [Abstract][Full Text] [Related]
16. INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells.
Min JW; Kim KI; Kim HA; Kim EK; Noh WC; Jeon HB; Cho DH; Oh JS; Park IC; Hwang SG; Kim JS
Biochem Biophys Res Commun; 2013 Oct; 440(1):137-42. PubMed ID: 24051093
[TBL] [Abstract][Full Text] [Related]
17. HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway.
Wang M; Qiao X; Cooper T; Pan W; Liu L; Hayball J; Lin J; Cui X; Zhou Y; Zhang S; Zou Y; Zhang R; Wang X
Cell Death Dis; 2020 Dec; 11(12):1049. PubMed ID: 33311486
[TBL] [Abstract][Full Text] [Related]
18. Phosphoinositide signaling in cancer: INPP4B Akt(s) out.
Woolley JF; Dzneladze I; Salmena L
Trends Mol Med; 2015 Sep; 21(9):530-2. PubMed ID: 26150301
[TBL] [Abstract][Full Text] [Related]
19. Expression and functional characterization of INPP4B in gallbladder cancer patients and gallbladder cancer cells.
Wu Y; Meng D; Xu X; Bao J; You Y; Sun Y; Li Y; Sun D
BMC Cancer; 2021 Apr; 21(1):433. PubMed ID: 33879096
[TBL] [Abstract][Full Text] [Related]
20. The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth.
Bago R; Sommer E; Castel P; Crafter C; Bailey FP; Shpiro N; Baselga J; Cross D; Eyers PA; Alessi DR
EMBO J; 2016 Sep; 35(17):1902-22. PubMed ID: 27481935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
